American Journal of Kidney Diseases
Volume 51, Issue 1 , Pages 5-9 , January 2008

Brain Natriuretic Peptide Therapy to Prevent Acute Kidney Injury After Cardiac Surgery

  • Patrick Murray, MD

      Affiliations

    • Corresponding Author InformationAddress correspondence to Patrick Murray, MD, University of Chicago Hospitals, Section of Nephrology, MC5100, University of Chicago Hospitals, 5841 S Maryland Ave, Chicago, IL 60637.

References 

  1. Mangano CM, Diamondstone LS, Ramsey JG, et al. Renal dysfunction after myocardial revascularization: Risk factors, adverse outcomes, and hospital resource utilization. Ann Intern Med. 1998;128:194–203
  2. Tuttle KR, Worrall NK, Dahlstrom LR, et al. Predictors of ARF after cardiac surgical procedures. Am J Kidney Dis. 2003;41:76–83
  3. Chertow GM, Lazarus JM, Christiansen CL, et al. Preoperative renal risk stratification. Circulation. 1997;95:878–884
  4. Lassnigg AL, Schmidlin D, Mouhieddine M, et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: A prospective cohort study. J Am Soc Nephrol. 2004;15:1597–1605
  5. Ryckwaert F, Boccara G, Frappier J-M, et al. Incidence, risk factors, and prognosis of a moderate increase in plasma creatinine after cardiac surgery. Crit Care Med. 2002;30:1495–1498
  6. Loef BG, Epema AH, Smilde TD, et al. Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and survival. J Am Soc Nephrol. 2005;16:195–200
  7. Leacche M, Rawn JD, Mihalijevic T, et al. Outcomes in patients with normal serum creatinine and with artificial renal support for acute renal failure developing after coronary artery bypass grafting. Am J Cardiol. 2004;93:353–356
  8. Conlon PJ, Stafford-Smith M, White WD, et al. Acute renal failure following cardiac surgery. Neph Dial Transplant. 1999;14:1158–1162
  9. Ruel M, Khan TA, Voisine P, et al. Vasomotor dysfunction after cardiac surgery. Eur J Cardiothorac Surg. 2004;26:1002–1014
  10. Tang I, Murray PT. Prevention of perioperative ARF: What works?. Best Pract Res Clin Anaesthesiol. 2004;18:91–111
  11. Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006;1:19–32
  12. Colucci WS, Elkayam U, Horton DP, et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. N Engl J Med. 2000;343:246–253
  13. Publication Committee for the VMAC Investigators. Intravenous nesiritide vs. nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA. 2002;287:1531–1540
  14. Sackner-Bernstein JD, Kowalski M, Fox M, et al. Short-term risk of death after treatment with nesiritide for decompensated heart failure (A pooled analysis of randomized controlled trials). JAMA. 2005;293:1900–1905
  15. Sackner-Bernstein JD, Skopicki HA, Aaronson KD. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation. 2005;111:1487–1491
  16. Topol EJ. Nesiritide—not verified. N Engl J Med. 2005;353:113–115
  17. Cataliotti A, Boerrigter G, Costello-Boerrigter LC, et al. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure. Circulation. 2004;109:1680–1685
  18. Feldman DS, Ikonomidis JS, Uber WE, et al. Human B-natriuretic peptide improves hemodynamics and renal function in heart transplant patients immediately after surgery. J Card Fail. 2004;10:292–296
  19. Salzberg SP, Filsoufi F, Anyanwu A, et al. High-risk mitral valve surgery: perioperative hemodynamic optimization with nesiritide (BNP). Ann Thorac Surg. 2005;80:502–506
  20. Beaver TM, Winterstein AG, Shuster JJ, et al. Effectiveness of nesiritide on dialysis or all-cause mortality in patients undergoing cardiothoracic surgery. Clin Cardiol. 2006;29:18–24
  21. Mentzer RM, Oz MC, Sladen RN, et al. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery (The NAPA Trial). J Am Coll Cardiol. 2007;49:716–726
  22. Bail DHL, Steger V, Heinzelmann U, et al. Administration of brain natriuretic peptide improves cardiac function following operations using extracorporeal circulation in an animal model. Clin Sci. 2007;112:315–324
  23. Chen HH, Sundt TM, Cook DJ, et al. Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary-bypass surgery: a double-blind placebo-controlled pilot. Circulation. 2007;116(suppl 11):1134–1138
  24. Sezai A, Shiono M, Orime Y, et al. Low-dose continuous infusion of human atrial natriuretic peptide during and after cardiac surgery. Ann Thorac Surg. 2000;69:732–738
  25. Sezai A, Hata M, Wakui S, et al. Efficacy of low-dose continuous infusion of human atrial natriuretic peptide (hANP) during cardiac surgery (Possibility of postoperative left ventricular remodeling effect). Circ J. 2006;70:1426–1431
  26. Sezai A, Hata M, Wakui S, et al. Efficacy of continuous low-dose hANP administration in patients undergoing emergent coronary artery bypass grafting for acute coronary syndrome. Circ J. 2007;71:1401–1407
  27. Sward K, Valsson F, Odencrants P, et al. Recombinant human atrial natriuretic peptide in ischemic acute renal failure (A randomized placebo controlled trial). Crit Care Med. 2004;32:1310–1315
  28. Allgren RL, Marbury TC, Rahman SN, et al. Anaritide in acute tubular necrosis (Auriculin Anaritide Acute Renal Failure Study Group). N Engl J Med. 1997;336:828–834
  29. Lewis J, Salm MM, Chertow GM, et al. Atrial natriuretic factor in oliguric acute renal failure (Anaritide Acute Renal Failure Study Group). Am J Kidney Dis. 2000;36:767–774
  30. Sands JM, Neylan JF, Olson RA, et al. Atrial natriuretic factor does not improve the outcome of cadaveric renal transplantation. J Am Soc Nephrol. 1991;1:1081–1086
  31. Ratcliffe PJ, Richardson AJ, Kirby JE, et al. Effect of intravenous infusion of atriopeptin 3 on immediate renal allograft function. Kidney Int. 1991;39:164–168
  32. Kurnik BR, Allgren RL, Genter FC, et al. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kid Dis. 1998;31:674–680
  33. Murray PT, Le Gall JR, Dos Reis Miranda D, et al. Physiologic endpoints (efficacy) for acute renal failure studies. Curr Opin Crit Care. 2002;8:519–525
  34. Palevsky PM, Metnitz PG, Piccinni P, et al. Selection of endpoints for clinical trials of acute renal failure in critically ill patients. Curr Opin Crit Care. 2002;8:515–518

PII: S0272-6386(07)01496-5

doi: 10.1053/j.ajkd.2007.11.006

American Journal of Kidney Diseases
Volume 51, Issue 1 , Pages 5-9 , January 2008

Article Tools